Trials / Terminated
TerminatedNCT05193695
How to Reduce Dry Needling Pain in Treatment of Trigger Points of Muscle Triceps Sural in Ankle Post Fracture Patients
Heat or Excesice in Treadmill as Techique to Reduce Dry Needling Pain in Treatment of Trigger Points of Muscle Triceps Sural in Ankle Post Fracture Patients
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Becerra, Pablo · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Ankle fractures are one of the main causes of hospitalization due to injuries in Chile, which also have a discharge and partial load time of approximately 12 weeks in the recovery process. This generates disuse and atrophy of the posterior musculature of the leg called the triceps sural, which makes it difficult to restart and perform the gait. We conducted this research because practically all patients with this type of diagnosis have trigger points in these muscles, and dry needling technique is one of the best for its treatment, but has the disadvantage that it produces post dry needling pain of 48 hours and there is not enough information, or consensus on which method is better to reduce post dry needling pain. This study aims to prove wich technique is most useful in reducing pain post dry needling for the treatment of trigger points in the triceps sural muscle in ankle post fracture patients.
Conditions
- Physical Therapy Modalities
- Pain Measurement
- Trigger Point Pain, Myofascial
- Ankle Fractures
- Rehabilitation
- Needles
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Treadmill exercise | the patients walked on a treadmill for 20 minutes after dry needling, with an inclination of 5 degrees and at a speed at which the perceived exertion was 5 according to the Borg CR10 scale (Chen et al., 2002) |
Timeline
- Start date
- 2018-08-09
- Primary completion
- 2019-04-04
- Completion
- 2019-04-30
- First posted
- 2022-01-18
- Last updated
- 2022-01-31
Locations
1 site across 1 country: Chile
Source: ClinicalTrials.gov record NCT05193695. Inclusion in this directory is not an endorsement.